Suchergebnisse - "Andreopoulou, Eleni"

PubPharm (84)

1

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer : MAINTAIN Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kalinsky, K. | Accordino, M. | Chiuzan, C. | +20

2

Benefit of Adjuvant Chemotherapy in Node-Negative T1a Versus T1b and T1c Triple Negative Breast Cancer

enthalten in: ResearchSquare.com | 2022

von Fasano, G. | Bayard, S. | Chen, Y. | +13

3

Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Fasano, G. | Bayard, S. | Chen, Y. | +14

4

Facts and Perspectives : Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer

enthalten in: Frontiers in oncology | 2022

von Schreier, A. | Zappasodi, R. | Serganova, I. | +3

5

Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Fasano, G. | Bayard, S. | Chen, Y. | +14

6

Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Fasano, G. | Bayard, S. | Chen, Y. | +14

7

Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Fasano, G. | Bayard, S. | Chen, Y. | +14

8

Alterations of the 70 kDa heat shock protein (HSP70) and sequestosome-1 (p62) in women with breast cancer

enthalten in: Scientific reports | 2021

von Orfanelli, T. | Giannopoulos, S. | Zografos, E. | +10

9

Expert Discussion : HER2-Positive Breast Cancer

enthalten in: Breast care (Basel, Switzerland) | 2021

von Foukakis, T. | Matikas, A. | Oikonomidou, O. | +2

10

Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

enthalten in: Breast cancer research and treatment | 2021

von Kearney, M. | Franks, L. | Lee, S. | +15

1
2
3
4
5
6
7
8
9
Nächster »
[9]